31 results

• Lawsuit Alleges Dupixent Caused Mycosis Fungoides Diagnosis

  July 21, 2026

  Irvin Jackson

  A Dupixent cancer lawsuit claims the manufacturers failed to adequately test and label the eczema treatment, resulting in a CTCL cancer diagnosis.

• Dupixent MDL Judge To Meet With Lawyers for Initial Case Management Conference in October 2026

  June 25, 2026

  Irvin Jackson

  A federal judge has scheduled the first Dupixent lawsuit MDL initial case management conference for October 1, 2026.

• Lawsuit Claims Dupixent Cancer Diagnosis Occurred After Only 8 Months of Use

  June 17, 2026

  Irvin Jackson

  The makers of Dupixent face a CTCL lawsuit by a man who says he developed the rare form of cancer less than a year after beginning treatment with the eczema drug.

• Dupixent Injection Lawsuits Consolidated in MDL Over CTCL Diagnoses

  June 9, 2026

  Irvin Jackson

  The U.S. Judicial Panel on Multidistrict Litigation has consolidated all Dupixent lawsuits in the District of New Jersey for pretrial proceedings.

• Dupixent Injection Lawsuit Alleges Manufacturer Failed to Warn About T-Cell Lymphoma Cancer Side Effects

  June 4, 2026

  Irvin Jackson

  Regeneron and Sanofi-Aventis face a Dupixent injection lawsuit from a Louisiana woman who says the companies knew about the drug's risks but downplayed them to doctors and patients.

• Dupixent Cancer Lawsuit Claims Eczema Drug Caused Woman’s CTCL Diagnosis

  May 28, 2026

  Michael Adams

  A Delaware woman has filed a Dupixent lawsuit, claiming manufacturers promoted the eczema drug as a breakthrough treatment while failing to warn that it may trigger or worsen CTCL, a rare form of non-Hodgkin’s lymphoma.

• Link Between Dupixent and Cancer Withheld From Doctors and Users, Lawsuit Alleges

  May 11, 2026

  Michael Adams

  A lawsuit alleges an Illinois woman developed CTCL after using Dupixent, raising concerns the manufacturer may have withheld concerns that the drug could contribute to cancer.

• Lawsuit Indicates Dupixent Lymphoma Diagnosis Resulted in Multiple Rounds of Chemotherapy

  May 1, 2026

  Irvin Jackson

  A Dupixent lawsuit claims use of the drug led to the diagnosis of two forms of CTCL cancer, requiring repeated chemotherapy treatment and life-long medical monitoring.

• Judges Will Consider MDL for Dupixent Cancer Lawsuits Late Next Month

  April 21, 2026

  Irvin Jackson

  A group of federal judges will determine whether all Dupixent cancer lawsuits should be formed into a multidistrict litigation, following oral arguments set for May 28.

• Dupixent Injections Caused Peripheral T-Cell Lymphoma (PTCL) Diagnosis: Lawsuit

  April 6, 2026

  Irvin Jackson

  An Illinois man's Dupixent injection lawsuit claims manufacturers knew, or should have known, about the potential T-cell cancer risks, but hid those problems from the public.